Alexion Pharma (Switzerland)

Alexion Pharma (Switzerland)

Alexion Pharmaceuticals, Inc., a subsidiary of AstraZeneca, is a pharmaceutical company headquartered in Boston, Massachusetts that specializes in orphan drugs to treat rare diseases. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Alexion Pharma (Switzerland), Switzerland, covering academic research published from 2000 to 2024. Read More.


Open Access Percentage

31%


Total
Publications

328


Total Open
Publications

102


Total
Citations

6.8K


Open Access
Percentage

31%


Total
Publications

328


Total Open
Publications

102


Total
Citations

6.8K

Wikipedia

Website

download

Breakdown

14% 13% 3% 70%

Publisher Open

14%

Both

13%

Other Platform Open

3%

Closed

70%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530Total Publications
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024

Open

Closed

Publisher Open

46%OA Journal

OA Journal 46%

40

Hybrid 21%

18

No Guarantees 33%

29

Other Platform Open

Domain 70%

37

Institution 30%

16

Other Internet 19%

10

Preprint 2%

1

Public 0%

0

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
37
DOI
Other Internet
9
University of Liège - Open Repository and Bibliography
Institution
2
National University of La Plata - El Servicio de Difusión de la Creación Intelectual
Institution
2
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
2
Ghent University - Ghent University Academic Bibliography
Institution
2
DANS - Data Archiving and Networked Services
Institution
2
Washington University School of Medicine - Digital Commons@Becker
Institution
1
Unknown Repository
Other Internet
1
Université de Lille (University Of Lille - LillOA)
Institution
1
1 / 3

Data updated 18 August 2025

Share

Share

Share